Immunovant
$14.529876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$14.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.65 (+4.69%) Today
$0.00 (0.00%) As of 4:02 PM EDT after-hours
Why Robinhood?
You can buy or sell Immunovant and other stocks, options, ETFs, and crypto commission-free!
About IMVT
Immunovant, Inc. Common Stock, also called Immunovant, is a clinical-stage biopharmaceutical company. Read More It focuses on enabling normal lives for patients with autoimmune diseases. The company was founded in 2018 and is headquartered in New York, NY.
Employees
—
Headquarters
New York, New York
Founded
2018
Market Cap
754.53M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
219.37K
High Today
$14.94
Low Today
$13.69
Open Price
$14.24
Volume
131.38K
52 Week High
$18.69
52 Week Low
$8.34